SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation
Eui Tae Kim,
Kathryn L. Roche,
Katarzyna Kulej,
Lynn A. Spruce,
Steven H. Seeholzer,
Donald M. Coen,
Felipe Diaz-Griffero,
Eain A. Murphy,
Matthew D. Weitzman
Affiliations
Eui Tae Kim
Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Protective Immunity and Division of Cancer Pathobiology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Kathryn L. Roche
Department of Translational Medicine, Baruch S. Blumberg Research Institute, Doylestown, PA 18902, USA; Evrys Bio, Pennsylvania Biotechnology Center, Doylestown, PA 18902, USA
Katarzyna Kulej
Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Protective Immunity and Division of Cancer Pathobiology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Lynn A. Spruce
Protein and Proteomics Core, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Steven H. Seeholzer
Protein and Proteomics Core, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Donald M. Coen
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
Felipe Diaz-Griffero
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Eain A. Murphy
Department of Translational Medicine, Baruch S. Blumberg Research Institute, Doylestown, PA 18902, USA; Evrys Bio, Pennsylvania Biotechnology Center, Doylestown, PA 18902, USA
Matthew D. Weitzman
Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Protective Immunity and Division of Cancer Pathobiology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Corresponding author
Summary: Cellular SAMHD1 inhibits replication of many viruses by limiting intracellular deoxynucleoside triphosphate (dNTP) pools. We investigate the influence of SAMHD1 on human cytomegalovirus (HCMV). During HCMV infection, we observe SAMHD1 induction, accompanied by phosphorylation via viral kinase UL97. SAMHD1 depletion increases HCMV replication in permissive fibroblasts and conditionally permissive myeloid cells. We show this is due to enhanced gene expression from the major immediate-early (MIE) promoter and is independent of dNTP levels. SAMHD1 suppresses innate immune responses by inhibiting nuclear factor κB (NF-κB) activation. We show that SAMHD1 regulates the HCMV MIE promoter through NF-κB activation. Chromatin immunoprecipitation reveals increased RELA and RNA polymerase II on the HCMV MIE promoter in the absence of SAMHD1. Our studies reveal a mechanism of HCMV virus restriction by SAMHD1 and show how SAMHD1 deficiency activates an innate immune pathway that paradoxically results in increased viral replication through transcriptional activation of the HCMV MIE gene promoter. : SAMHD1 has been identified as a cellular antiviral restriction factor. Kim et al. report that HCMV is restricted by SAMHD1 through inhibition of viral gene expression. They show that depletion of SAMHD1 increases activation of the NF-κB immune pathway, which paradoxically increases gene expression from the immediate-early viral promoter. Keywords: SAMHD1, human cytomegalovirus, HCMV, NF-κB, virus restriction